{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T23:43:58Z","timestamp":1780357438209,"version":"3.54.1"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2018,1,31]],"date-time":"2018-01-31T00:00:00Z","timestamp":1517356800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100002322","name":"Coordination for the Improvement of Higher Education Personnel","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001807","name":"FAPESP","doi-asserted-by":"crossref","award":["FAPESP (2015-23555-3"],"award-info":[{"award-number":["FAPESP (2015-23555-3"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001807","name":"FAPESP","doi-asserted-by":"crossref","award":["2015-21237-4)."],"award-info":[{"award-number":["2015-21237-4)."]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1007\/s12032-018-1079-6","type":"journal-article","created":{"date-parts":[[2018,1,31]],"date-time":"2018-01-31T13:40:06Z","timestamp":1517406006000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Expression of Hippo signaling pathway and Aurora kinase genes in chronic myeloid leukemia"],"prefix":"10.1007","volume":"35","author":[{"given":"Ana Paula Zambuzi Cardoso","family":"Marsola","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Belinda Pinto","family":"Sim\u00f5es","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo Carvalho","family":"Palma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Gabriela","family":"Berzoti-Coelho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra Mara","family":"Burin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fab\u00edola Atti\u00e9","family":"de Castro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,1,31]]},"reference":[{"issue":"6","key":"1079_CR1","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1038\/nrc2147","volume":"7","author":"JV Melo","year":"2007","unstructured":"Melo JV, Barnes DJ. Chronic myeloid leukemia as a model of disease evolution in human cancer. Nat Rev Cancer. 2007;7(6):441\u201353.","journal-title":"Nat Rev Cancer"},{"issue":"7","key":"1079_CR2","first-page":"2049","volume":"60","author":"MW Deininger","year":"2000","unstructured":"Deininger MW, Vieira S, Mendiola R, et al. BCR\u2013ABL1 tyrosine kinase activity regulates the expression of multiple genes implicated in the pathogenesis of chronic myeloid leukemia. Cancer Res. 2000;60(7):2049\u201355.","journal-title":"Cancer Res"},{"issue":"6","key":"1079_CR3","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1158\/1078-0432.CCR-06-2320","volume":"13","author":"D Perrotti","year":"2007","unstructured":"Perrotti D, Neviani P. From mRNA metabolism to cancer therapy: chronic myelogenous leukemia shows the way. Clin Cancer Res. 2007;13(6):1638\u201342.","journal-title":"Clin Cancer Res"},{"issue":"9584","key":"1079_CR4","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/S0140-6736(07)61165-9","volume":"370","author":"R Hehlmann","year":"2007","unstructured":"Hehlmann R, Hochhaus A, Baccarani M. Chronic myeloid leukaemia. Lancet. 2007;370(9584):342\u201350.","journal-title":"Lancet"},{"issue":"1","key":"1079_CR5","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.exphem.2003.10.001","volume":"32","author":"JM Goldman","year":"2004","unstructured":"Goldman JM. Chronic myeloid leukemia: still a few questions. Exp Hematol. 2004;32(1):2\u201310.","journal-title":"Exp Hematol"},{"issue":"35","key":"1079_CR6","doi-asserted-by":"publisher","first-page":"6041","DOI":"10.1200\/JCO.2009.25.0779","volume":"27","author":"M Baccarani","year":"2009","unstructured":"Baccarani M, Cortes J, Pane F, Niederwieser D, Saglio G, Apperley J, et al. Chronic myeloid leukemia: an update of concepts and management recommendations of European LeukemiaNet. J Clin Oncol. 2009;27(35):6041\u201351.","journal-title":"J Clin Oncol"},{"issue":"4","key":"1079_CR7","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1182\/blood.V63.4.789.789","volume":"63","author":"JE Sokal","year":"1984","unstructured":"Sokal JE, Cox EB, Baccarani M, et al. Prognostic discrimination in \u201cgood-risk\u201d chronic granulocytic leukemia. Blood. 1984;63(4):789\u201399.","journal-title":"Blood"},{"issue":"10","key":"1079_CR8","doi-asserted-by":"publisher","first-page":"2275","DOI":"10.1002\/ijc.29073","volume":"137","author":"Y Ma","year":"2015","unstructured":"Ma Y, Yang Y, Wang F, et al. Hippo-YAP signaling pathway: a new paradigm for cancer therapy. Int J Cancer. 2015;137(10):2275\u201386.","journal-title":"Int J Cancer"},{"issue":"2","key":"1079_CR9","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/nrc3876","volume":"15","author":"T Moroishi","year":"2015","unstructured":"Moroishi T, Hansen CG, Guan KL. The emerging roles of YAP and TAZ in cancer. Nat Rev Cancer. 2015;15(2):73\u20139.","journal-title":"Nat Rev Cancer"},{"issue":"9","key":"1079_CR10","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1101\/gad.1909210","volume":"24","author":"B Zhao","year":"2010","unstructured":"Zhao B, Li L, Lei Q, Guan KL. The Hippo-YAP pathway in organ size control and tumorigenesis: an updated version. Genes Dev. 2010;24(9):862\u201374. https:\/\/doi.org\/10.1101\/gad.1909210 .","journal-title":"Genes Dev"},{"key":"1079_CR11","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1242\/dev.121.4.1053","volume":"121","author":"T Xu","year":"1995","unstructured":"Xu T, Wang WS, Stewart RA, et al. Identifying tumor suppressors in genetic mosaics: the drosophila lats gene encodes a putative protein kinase. Development. 1995;121:1053\u201363.","journal-title":"Development"},{"key":"1079_CR12","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1101\/gad.9.5.534","volume":"9","author":"RW Justice","year":"1995","unstructured":"Justice RW, Zilian O, Woods DF, et al. The drosophila tumor suppressor gene warts encodes a homolog of human myotonic dystrophy kinase and is required for the control of cell shape and proliferation. Genes Dev. 1995;9:534\u201346.","journal-title":"Genes Dev"},{"key":"1079_CR13","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/5960","volume":"21","author":"W Tao","year":"1999","unstructured":"Tao W, Zhang S, Turenchalk GS, et al. Human homologue of the drosophila melanogaster lats tumor suppressor modulates CDC2 activity. Nat Genet. 1999;21:177\u201381.","journal-title":"Nat Genet"},{"key":"1079_CR14","doi-asserted-by":"publisher","first-page":"3101","DOI":"10.1038\/sj.onc.1203659","volume":"19","author":"T Hori","year":"2000","unstructured":"Hori T, Takaori-Kondo A, Kamikubo Y, et al. Molecular cloning of a novel human protein kinase, kpm, that is homologous to warts\/lats, a drosophila tumor suppressor. Oncogene. 2000;19:3101\u20139.","journal-title":"Oncogene"},{"key":"1079_CR15","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1006\/geno.1999.6065","volume":"63","author":"N Yabuta","year":"2000","unstructured":"Yabuta N, Fujii T, Copeland NG, et al. Structure, expression and chromosome mapping of LATS2, a mammalian homologue of the drosophila tumor suppressor gene lats\/warts. Genomics. 2000;63:263\u201370.","journal-title":"Genomics"},{"key":"1079_CR16","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.cell.2006.01.005","volume":"124","author":"BA Edgar","year":"2006","unstructured":"Edgar BA. From cell structure to transcription: Hippo forges a new path. Cell. 2006;124:267\u201373.","journal-title":"Cell"},{"key":"1079_CR17","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1101\/gad.1536007","volume":"21","author":"D Pan","year":"2007","unstructured":"Pan D. Hippo signaling in organ size control. Genes Dev. 2007;21:886\u201397.","journal-title":"Genes Dev"},{"key":"1079_CR18","doi-asserted-by":"publisher","first-page":"12405","DOI":"10.1073\/pnas.0605579103","volume":"103","author":"M Overholtzer","year":"2006","unstructured":"Overholtzer M, Zhang J, Smolen GA, et al. Transforming properties of YAP, a candidate oncogene on the chromosome 11q22 amplicon. Proc Natl Acad Sci USA. 2006;103:12405\u201310.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1079_CR19","doi-asserted-by":"publisher","first-page":"5496","DOI":"10.1074\/jbc.M709037200","volume":"283","author":"Y Hao","year":"2008","unstructured":"Hao Y, Chun A, Cheung K, et al. Tumor suppressor LATS1 is a negative regulator of oncogene YAP. J Biol Chem. 2008;283:5496\u2013509.","journal-title":"J Biol Chem"},{"key":"1079_CR20","doi-asserted-by":"publisher","first-page":"2426","DOI":"10.1128\/MCB.01874-07","volume":"28","author":"QY Lei","year":"2008","unstructured":"Lei QY, Zhang H, Zhao B, et al. TAZ promotes cell proliferation and epithelial mesenchymal transition and is inhibited by the hippo pathway. Mol Cell Biol. 2008;28:2426\u201336.","journal-title":"Mol Cell Biol"},{"key":"1079_CR21","doi-asserted-by":"publisher","first-page":"2076","DOI":"10.1038\/sj.onc.1208445","volume":"24","author":"H Chan","year":"2005","unstructured":"Chan H, Nousiainen M, Chalamalasetty RB, et al. The Ste20-like kinase Mst2 activates the human large tumor suppressor kinase Lats1. Oncogene. 2005;24:2076\u201386.","journal-title":"Oncogene"},{"key":"1079_CR22","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.cub.2008.02.006","volume":"18","author":"M Praskova","year":"2008","unstructured":"Praskova M, Xia F, Avruch J. MOBKL1A\/MOBKL1B phosphorylation by MST1 and MST2 inhibits cell proliferation. Curr Biol. 2008;18:311\u201321.","journal-title":"Curr Biol"},{"key":"1079_CR23","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.bbrc.2006.03.244","volume":"345","author":"A Hergovich","year":"2006","unstructured":"Hergovich A, Schmitz D, Hemmings BA. The human tumour suppressor LATS1 is activated by human MOB1 at the membrane. Biochem Biophys Res Commun. 2006;345:50\u20138.","journal-title":"Biochem Biophys Res Commun"},{"key":"1079_CR24","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/j.cell.2011.09.048","volume":"147","author":"M Cordenonsi","year":"2011","unstructured":"Cordenonsi M, Zanconato F, Azzolin L, et al. The Hippo transducer TAZ confers cancer stem cell-related traits on breast cancer cells. Cell. 2011;147:759\u201372.","journal-title":"Cell"},{"issue":"6","key":"1079_CR25","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1038\/onc.2014.5","volume":"4","author":"M Bartucci","year":"2014","unstructured":"Bartucci M, Dattilo R, Moriconi C, et al. TAZ is required for metastatic activity and chemoresistance of breast cancer stem cells. Oncogene. 2014;4(6):681\u201390.","journal-title":"Oncogene"},{"issue":"10","key":"1079_CR26","doi-asserted-by":"publisher","first-page":"2413","DOI":"10.3109\/10428194.2014.891028","volume":"55","author":"JA Machado-Neto","year":"2014","unstructured":"Machado-Neto JA, de Melo Campos P, Olalla Saad ST, et al. YAP1 expression in myelodysplastic syndromes and acute leukemias. Leuk Lymphoma. 2014;55(10):2413\u20135.","journal-title":"Leuk Lymphoma"},{"issue":"9","key":"1079_CR27","doi-asserted-by":"publisher","first-page":"2189","DOI":"10.3109\/10428194.2013.867493","volume":"55","author":"S Safari","year":"2014","unstructured":"Safari S, Movafagh A, Zare-Adollahi D, et al. MST1\/2 and YAP1 gene expression in acute myeloid leukemia. Leuk Lymphoma. 2014;55(9):2189\u201391.","journal-title":"Leuk Lymphoma"},{"key":"1079_CR28","doi-asserted-by":"publisher","first-page":"e54211","DOI":"10.1371\/journal.pone.0054211","volume":"8","author":"HF Yuen","year":"2013","unstructured":"Yuen HF, McCrudden CM, Huang YH, et al. TAZ expression as a prognostic indicator in colorectal cancer. PLoS ONE. 2013;8:e54211. https:\/\/doi.org\/10.1371\/journal.pone.0054211","journal-title":"PLoS ONE"},{"issue":"5","key":"1079_CR29","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1111\/j.1365-2141.2011.08898.x","volume":"5","author":"SS Farag","year":"2011","unstructured":"Farag SS. The potential role of aurora kinase inhibitors in haematological malignancies. Br J Haematol. 2011;5(5):561\u201379.","journal-title":"Br J Haematol"},{"issue":"16","key":"1079_CR30","doi-asserted-by":"publisher","first-page":"2724","DOI":"10.4161\/cc.10.16.16873","volume":"10","author":"N Yabuta","year":"2011","unstructured":"Yabuta N, Mukai S, Okada N, et al. The tumor suppressor Lats2 is pivotal in Aurora A and Aurora B signaling during mitosis. Cell Cycle. 2011;10(16):2724\u201336.","journal-title":"Cell Cycle"},{"key":"1079_CR31","volume-title":"WHO classification of tumors of haematopoietic and lymphoid tissues","author":"SH Swerdlow","year":"2008","unstructured":"Swerdlow SH, Campo E, Harris NL, et al. WHO classification of tumors of haematopoietic and lymphoid tissues. 4th ed. Lyon: World Health Organization (WHO)\/IARC; 2008.","edition":"4"},{"issue":"6","key":"1079_CR32","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1038\/onc.2014.5","volume":"34","author":"M Bartucci","year":"2015","unstructured":"Bartucci M, Dattilo R, Moriconi C, et al. TAZ is required for metastatic activity and chemoresistance of breast cancer stem cells. Oncogene. 2015;34(6):681\u201390.","journal-title":"Oncogene"},{"issue":"6","key":"1079_CR33","doi-asserted-by":"publisher","first-page":"e65539","DOI":"10.1371\/journal.pone.0065539","volume":"8","author":"L Wang","year":"2013","unstructured":"Wang L, Shi S, Guo Z, et al. Overexpression of YAP and TAZ is an independent predictor of prognosis in colorectal cancer and related to the proliferation and metastasis of colon cancer cells. PLoS ONE. 2013;8(6):e65539.","journal-title":"PLoS ONE"},{"key":"1079_CR34","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1038\/onc.2009.69","volume":"28","author":"S Boehrer","year":"2009","unstructured":"Boehrer S, Ad\u00e8s L, Tajeddine N, et al. Suppression of the DNA damage response in acute myeloid leukemia versus myelodysplastic syndrome. Oncogene. 2009;28:2205\u201318.","journal-title":"Oncogene"},{"key":"1079_CR35","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1038\/leu.2011.94","volume":"25","author":"DK Walters","year":"2011","unstructured":"Walters DK, Wu X, Tschumper RC, et al. Evidence for ongoing DNA damage in multiple myeloma cells as revealed by constitutive phosphorylation of H2AX. Leukemia. 2011;25:1344\u201353.","journal-title":"Leukemia"},{"key":"1079_CR36","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1038\/nm.3562","volume":"20","author":"F Cottini","year":"2014","unstructured":"Cottini F, Hideshima T, Xu C, et al. Rescue of Hippo coactivator YAP1 triggers DNA damage-induced apoptosis in hematological cancers. Nat Med. 2014;20:599\u2013606.","journal-title":"Nat Med"},{"key":"1079_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1101\/gad.274027.115","volume":"30","author":"Z Meng","year":"2016","unstructured":"Meng Z, Moroishi T, Guan KL. Mechanisms of Hippo pathway regulation. Genes Dev. 2016;30:1\u201317.","journal-title":"Genes Dev"},{"key":"1079_CR38","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1038\/cdd.2013.83","volume":"20","author":"N Reuven","year":"2013","unstructured":"Reuven N, Adler J, Meltser V, et al. The Hippo pathway kinase Lats2 prevents DNA damage-induced apoptosis through inhibition of the tyrosine kinase c-Abl. Cell Death Differ. 2013;20:1330\u201340.","journal-title":"Cell Death Differ"},{"key":"1079_CR39","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.neo.2017.03.001","volume":"19","author":"Sasi","year":"2017","unstructured":"Sasi, et al. DDK promotes tumor chemoresistance and survival via multiple pathways. Neoplasia. 2017;19:439\u201350.","journal-title":"Neoplasia"},{"issue":"4","key":"1079_CR40","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1159\/000369446","volume":"133","author":"AF Ferreira","year":"2015","unstructured":"Ferreira AF, de Oliveira GL, Tognon R, et al. Apoptosis-related gene expression profile in chronic myeloid leukemia patients after imatinib mesylate and dasatinib therapy. Acta Haematol. 2015;133(4):354\u201364.","journal-title":"Acta Haematol"},{"key":"1079_CR41","first-page":"6588","volume":"52","author":"H Nakai","year":"1992","unstructured":"Nakai H, Misawa S, Toguchida J, et al. Frequent p53 gene mutations in blast crisis of chronic myelogenous leukemia, especially in myeloid crisis harboring loss of chromosome 17p. Cancer Res. 1992;52:6588\u201393.","journal-title":"Cancer Res"},{"issue":"4","key":"1079_CR42","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1016\/j.bbrc.2015.05.115","volume":"463","author":"T Tian","year":"2015","unstructured":"Tian T, Li A, Lu H, et al. TAZ promotes temozolomide resistance by upregulating MCL-1 in human glioma cells. Biochem Biophys Res Commun. 2015;463(4):638\u201343.","journal-title":"Biochem Biophys Res Commun"},{"issue":"6","key":"1079_CR43","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1016\/j.ceb.2003.10.013","volume":"15","author":"PD Andrews","year":"2003","unstructured":"Andrews PD, Knatko E, Moore WJ, et al. Mitotic mechanics: the Auroras come into view. Curr Opin Cell Biol. 2003;15(6):672\u201383.","journal-title":"Curr Opin Cell Biol"},{"issue":"5","key":"1079_CR44","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1111\/j.1365-2141.2011.08898.x","volume":"155","author":"SS Farag","year":"2011","unstructured":"Farag SS. The potential role of aurora kinase inhibitors in haematological malignancies. Br J Haematol. 2011;155(5):561\u201379.","journal-title":"Br J Haematol"},{"key":"1079_CR45","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1038\/labinvest.2009.106","volume":"89","author":"T Ikezoe","year":"2009","unstructured":"Ikezoe T, Takeuchi T, Yang J, et al. Analysis of Aurora B kinase in non-Hodgkin lymphoma. Lab Invest. 2009;89:1364\u201373.","journal-title":"Lab Invest"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12032-018-1079-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-018-1079-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-018-1079-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,13]],"date-time":"2022-08-13T16:42:55Z","timestamp":1660408975000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12032-018-1079-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,31]]},"references-count":45,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["1079"],"URL":"https:\/\/doi.org\/10.1007\/s12032-018-1079-6","relation":{},"ISSN":["1357-0560","1559-131X"],"issn-type":[{"value":"1357-0560","type":"print"},{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,31]]},"assertion":[{"value":"7 November 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 January 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants complied with the ethical standards of the institutional and\/or national research committee and with the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"All the patients and healthy individuals who participated in this study signed the Informed Consent Form.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}],"article-number":"26"}}